As of early August 2026, the CDC has confirmed 2,465 measles cases in the United States, already exceeding the full-year 2025 total of 2,289, with 94% linked to ongoing outbreaks and 92% occurring among unvaccinated or unknown-status individuals. This resurgence stems from declining MMR vaccination coverage below the 95% herd immunity threshold in multiple communities, enabling sustained local transmission of the highly contagious paramyxovirus. Official surveillance from the CDC and Johns Hopkins tracks weekly case reports and outbreak counts, highlighting risks to measles elimination status under WHO criteria. Traders should monitor upcoming CDC updates for case thresholds, new outbreaks, and vaccination data releases that could shift totals before year-end.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · AggiornatoCasi di morbillo negli Stati Uniti nel 2026?
Casi di morbillo negli Stati Uniti nel 2026?
$7,825,858 Vol.
$7,825,858 Vol.
31 dic 2026
↑4,5k
28%
↑3k
95%
↑3,5k
92%
↑4k
64%
↑5k
20%
↑7,5k
12%
↑10k
6%
↑12,5k
5%
$7,825,858 Vol.
$7,825,858 Vol.
31 dic 2026
↑4,5k
$20 Vol.
28%
↑3k
$89,478 Vol.
95%
↑3,5k
$13,530 Vol.
92%
↑4k
$218,125 Vol.
64%
↑5k
$229,577 Vol.
20%
↑7,5k
$185,009 Vol.
12%
↑10k
$6,514,436 Vol.
6%
↑12,5k
$349,917 Vol.
5%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of early August 2026, the CDC has confirmed 2,465 measles cases in the United States, already exceeding the full-year 2025 total of 2,289, with 94% linked to ongoing outbreaks and 92% occurring among unvaccinated or unknown-status individuals. This resurgence stems from declining MMR vaccination coverage below the 95% herd immunity threshold in multiple communities, enabling sustained local transmission of the highly contagious paramyxovirus. Official surveillance from the CDC and Johns Hopkins tracks weekly case reports and outbreak counts, highlighting risks to measles elimination status under WHO criteria. Traders should monitor upcoming CDC updates for case thresholds, new outbreaks, and vaccination data releases that could shift totals before year-end.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Mercato aperto: Feb 16, 2026, 11:51 AM ET
Volume
$7,825,858Data di fine
31 dic 2026Mercato aperto
Feb 16, 2026, 11:51 AM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of early August 2026, the CDC has confirmed 2,465 measles cases in the United States, already exceeding the full-year 2025 total of 2,289, with 94% linked to ongoing outbreaks and 92% occurring among unvaccinated or unknown-status individuals. This resurgence stems from declining MMR vaccination coverage below the 95% herd immunity threshold in multiple communities, enabling sustained local transmission of the highly contagious paramyxovirus. Official surveillance from the CDC and Johns Hopkins tracks weekly case reports and outbreak counts, highlighting risks to measles elimination status under WHO criteria. Traders should monitor upcoming CDC updates for case thresholds, new outbreaks, and vaccination data releases that could shift totals before year-end.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026 according to the CDC case counter between January 1, 2026, 12:00 AM ET and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volume
$7,825,858Data di fine
31 dic 2026Mercato aperto
Feb 16, 2026, 11:51 AM ETResolver
0x65070BE91...As of early August 2026, the CDC has confirmed 2,465 measles cases in the United States, already exceeding the full-year 2025 total of 2,289, with 94% linked to ongoing outbreaks and 92% occurring among unvaccinated or unknown-status individuals. This resurgence stems from declining MMR vaccination coverage below the 95% herd immunity threshold in multiple communities, enabling sustained local transmission of the highly contagious paramyxovirus. Official surveillance from the CDC and Johns Hopkins tracks weekly case reports and outbreak counts, highlighting risks to measles elimination status under WHO criteria. Traders should monitor upcoming CDC updates for case thresholds, new outbreaks, and vaccination data releases that could shift totals before year-end.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · Aggiornato
Fai attenzione ai link esterni.
Fai attenzione ai link esterni.
Domande frequenti